Hyonate vet.
Active substance
ATC code
Species
Horses.
Indications
For the treatment of lameness in horses due to non-infectious inflammation of joints
Dose to be administered and administration route
Intravenous or intraarticular use.
The recommended dose is:
- Intravenous: 4 ml (corresponding to 40 mg sodium hyaluronate)
- Intraarticular: 2 ml (corresponding to 20 mg sodium hyaluronate)
Three treatments at weekly intervals. Fewer treatments may be required if early improvement is observed.
Strict aseptic technique should be observed when injecting the veterinary medicinal product. As with any intraarticular procedure, proper injection site disinfection and animal restraint are very important. Excess synovial fluid should be aseptically removed prior to injection. Care should be taken not to scratch the cartilage surface with the point of the injection needle. For best results, the horse should be given three days stable rest after intraarticular treatment before gradually resuming normal activity.
Adverse reactions
Horses:
|
Very rare (<1 animal / 10 000 animals treated, including isolated reports): |
Injection site joint reaction1 (e.g. injection site swelling2) |
1 After intraarticular injection.
2 Diffuse swelling lasting 23-48 hours resulting from irritation by the needle while in the joint space. These may be acute but will generally resolve without sequelae within a few days.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Dispensing
POM-V - Prescription Only Medicine – Veterinarian
TRUSTED SOURCE
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 08327/4272 |
| EAN | 3661103049302 |
